glp 1 agonist parkinson GLP-1 Receptor Agonists: A New Treatment in Parkinson's Disease Frontiers | Glucagon-like peptide 1

Nanoparticles co-loaded with DFO and antioxidants show synergistic effects in TBI (Huang et al., 2024)

The following groups can safely use glutathione to improve skin quality: Individuals with uneven skin tone and pigmentary disorders, including melasma, sunspots, and age spots

When claims are drawn from these sources, they are attributed to "Omzo's published materials" or "per Omzo's Terms." FDA.gov primary sources: The FDA's public page on unapproved GLP-1 drugs, the April 30, 2026 FDA press release on the 503B Bulks List proposal, and the Federal Register notice 91 Fed

Interestingly, a cross-sectional study investigated the relationship between PhA and inflammation (measured by C-reactive protein, CRP) in 15 patients with PWS (28 6.8 years, 43.8 10.7 kg/m 2 ) compared to gender-, age-, and BMI- matched individuals without PWS (n = 15, 30 6.9 years, 43.9 8.8 kg/m 2 ) [80]

Nat Rev Gastroenterol Hepatol 2018